The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
Open accessAbstract
The considerable progress made in the field of cancer treatment has led to a dramatic improvement in the prognosis of patients with cancer. However, toxicities resulting from these treatments represent a cost that can be harmful to short‐ and long‐term outcomes. Adverse events affecting the cardiovascular system are one of the greatest challenges in the overall management of patients with cancer, as they can compromise the success of the optimal treatment against the tumor. Such adverse events are associated not only with older chemotherapy drugs such as anthracyclines but also with many targeted therapies and immunotherapies. Recognizing this concern, several American and European governing societies in oncology and cardiology have published guidelines on the cardiovascular monitoring of patients receiving potentially cardiotoxic cancer therapies, as well as on the management of cardiovascular toxicities. However, the low level of evidence supporting these guidelines has led to numerous discrepancies, leaving clinicians without a consensus strategy to apply. A cardio‐oncology expert panel from the French Working Group of Cardio‐Oncology has undertaken an ambitious effort to analyze and harmonize the most recent American and European guidelines to propose roadmaps and decision algorithms that would be easy for clinicians to use in their daily practice. In this statement, the experts addressed the cardiovascular monitoring strategies for the cancer drugs associated with the highest risk of cardiovascular toxicities, as well as the management of such toxicities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx225 · Cited by 2,367
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,795
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Salem, J.-E., Manouchehri, A., Moey, M., Lebrun-Vignes, B., Bastarache, L., Pariente, A., Gobert, A., Spano, J.-P., Balko, J. M., Bonaca, M. P., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30608-9 · Cited by 1,271
Self-citationPlana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu192 · Cited by 1,058
Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.023 · Cited by 1,031
Cardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,026
Cardinale, D., Sandri, M. T., Colombo, A., Colombo, N., Boeri, M., Lamantia, G., Civelli, M., Peccatori, F., Martinelli, G., Fiorentini, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130926.51766.cc · Cited by 955
Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W. (2010) · Circulation · doi:10.1161/circulationaha.109.192704 · Cited by 821
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Armstrong, G. T., Oeffinger, K. C., Chen, Y., Kawashima, T., Yasui, Y., Leisenring, W., Stovall, M., Chow, E. J., Sklar, C. A., Mulrooney, D. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3205 · Cited by 734
Risk of Arterial Thromboembolism in Patients With Cancer
Navi, B. B., Reiner, A. S., Kamel, H., Iadecola, C., Okin, P. M., Elkind, M. S. V., Panageas, K. S., & DeAngelis, L. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.047 · Cited by 654
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Moslehi, J. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1100265 · Cited by 635
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
Dolladille, C., Ederhy, S., Sassier, M., Cautela, J., Thuny, F., Cohen, A. A., Fedrizzi, S., Chrétien, B., Da-Silva, A., Plane, A.-F., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0726 · Cited by 587
Self-citationLeft ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Tricca LabTech, A., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Cipolla, C. M., & Fiorentini, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00748-8 · Cited by 551
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity
Escudier, M., Cautela, J., Malissen, N., Ancedy, Y., Orabona, M., Pinto, J., Monestier, S., Grob, J.-J., Scemama, U., Jacquier, A., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.030571 · Cited by 517
Self-citationCardiovascular toxicities associated with immune checkpoint inhibitors
Hu, J.-R., Florido, R., Lipson, E. J., Naidoo, J., Ardehali, R., Tocchetti, C. G., Lyon, A. R., Padera, R. F., Johnson, D. B., & Moslehi, J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz026 · Cited by 508
Fallah-Rad, N., Walker, J. R., Wassef, A., Lytwyn, M., Bohonis, S., Fang, T., Tian, G., Kirkpatrick, I. D. C., Singal, P. K., Krahn, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.063 · Cited by 484
Bonaca, M. P., Olenchock, B. A., Salem, J.-E., Wiviott, S. D., Ederhy, S., Cohen, A., Stewart, G. C., Choueiri, T. K., Di Carli, M., Allenbach, Y., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.034497 · Cited by 458
Self-citationTyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
Moslehi, J. J., & Deininger, M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.4718 · Cited by 443
Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
Salem, J.-E., Allenbach, Y., Vozy, A., Brechot, N., Johnson, D. B., Moslehi, J. J., & Kerneis, M. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1901677 · Cited by 443
Self-citationRate-corrected QT interval: Techniques and limitations
Funck-Brentano, C., & Jaillon, P. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90035-b · Cited by 401
Cancer survival: global surveillance will stimulate health policy and improve equity
Coleman, M. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62225-4 · Cited by 370
Prevention of Torsade de Pointes in Hospital Settings
Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.001 · Cited by 367
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
Zhang, L., Awadalla, M., Mahmood, S. S., Nohria, A., Hassan, M. Z. O., Thuny, F., Zlotoff, D. A., Murphy, S. P., Stone, J. R., Golden, D. L. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa051 · Cited by 355
Self-citationCardio-Oncology Services: rationale, organization, and implementation
Lancellotti, P., Suter, T. M., López-Fernández, T., Galderisi, M., Lyon, A. R., Van der Meer, P., Cohen Solal, A., Zamorano, J.-L., Jerusalem, G., Moonen, M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy453 · Cited by 311
Self-citationAichberger, K. J., Herndlhofer, S., Schernthaner, G., Schillinger, M., Mitterbauer‐Hohendanner, G., Sillaber, C., & Valent, P. (2011) · American Journal of Hematology · doi:10.1002/ajh.22037 · Cited by 296
Cardiovascular Complications of Cancer Therapy
Chang, H.-M., Okwuosa, T. M., Scarabelli, T., Moudgil, R., & Yeh, E. T. H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1095 · Cited by 290
López-Sendón, J., Álvarez-Ortega, C., Zamora Auñon, P., Buño Soto, A., Lyon, A. R., Farmakis, D., Cardinale, D., Canales Albendea, M., Feliu Batlle, J., Rodríguez Rodríguez, I., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa006 · Cited by 289
Cardiovascular Toxicities Associated With Ibrutinib
Salem, J.-E., Manouchehri, A., Bretagne, M., Lebrun-Vignes, B., Groarke, J. D., Johnson, D. B., Yang, T., Reddy, N. M., Funck-Brentano, C., Brown, J. R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.056 · Cited by 266
Self-citationAbdel-Qadir, H., Ethier, J.-L., Lee, D. S., Thavendiranathan, P., & Amir, E. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.12.002 · Cited by 251
Cardinale, D., Ciceri, F., Latini, R., Franzosi, M. G., Sandri, M. T., Civelli, M., Cucchi, G., Menatti, E., Mangiavacchi, M., Cavina, R., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.02.005 · Cited by 239
Impact of Comorbidity on Chemotherapy Use and Outcomes in Solid Tumors: A Systematic Review
Lee, L., Cheung, W. Y., Atkinson, E., & Krzyzanowska, M. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3049 · Cited by 237
Baumert, M., Porta, A., Vos, M. A., Malik, M., Couderc, J.-P., Laguna, P., Piccirillo, G., Smith, G. L., Tereshchenko, L. G., & Volders, P. G. A. (2016) · Europace · doi:10.1093/europace/euv405 · Cited by 234
Kim, T. D., Rea, D., Schwarz, M., Grille, P., Nicolini, F. E., Rosti, G., Levato, L., Giles, F. J., Dombret, H., Mirault, T., et al. (2013) · Leukemia · doi:10.1038/leu.2013.70 · Cited by 233
Virani, S. A., Dent, S., Brezden-Masley, C., Clarke, B., Davis, M. K., Jassal, D. S., Johnson, C., Lemieux, J., Paterson, I., Sebag, I. A., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.078 · Cited by 231
Cardiovascular Health of Patients With Cancer and Cancer Survivors
Barac, A., Murtagh, G., Carver, J. R., Chen, M. H., Freeman, A. M., Herrmann, J., Iliescu, C., Ky, B., Mayer, E. L., Okwuosa, T. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.059 · Cited by 229
Armenian, S. H., Armstrong, G. T., Aune, G., Chow, E. J., Ehrhardt, M. J., Ky, B., Moslehi, J., Mulrooney, D. A., Nathan, P. C., Ryan, T. D., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.3920 · Cited by 229
Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
Esfahani, K., Buhlaiga, N., Thébault, P., Lapointe, R., Johnson, N. A., & Miller, W. H. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1903064 · Cited by 224
Mulrooney, D. A., Armstrong, G. T., Huang, S., Ness, K. K., Ehrhardt, M. J., Joshi, V. M., Plana, J. C., Soliman, E. Z., Green, D. M., Srivastava, D., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0424 · Cited by 220
Campia, U., Moslehi, J. J., Amiri-Kordestani, L., Barac, A., Beckman, J. A., Chism, D. D., Cohen, P., Groarke, J. D., Herrmann, J., Reilly, C. M., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000641 · Cited by 217
Vascular Complications of Cancer Chemotherapy
Cameron, A. C., Touyz, R. M., & Lang, N. N. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.12.023 · Cited by 214
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies
Li, W., Croce, K., Steensma, D. P., McDermott, D. F., Ben-Yehuda, O., & Moslehi, J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.025 · Cited by 201
Cornell, R. F., Ky, B., Weiss, B. M., Dahm, C. N., Gupta, D. K., Du, L., Carver, J. R., Cohen, A. D., Engelhardt, B. G., Garfall, A. L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00231 · Cited by 198
Self-citationAnticoagulation Strategies in Patients With Cancer
Mosarla, R. C., Vaduganathan, M., Qamar, A., Moslehi, J., Piazza, G., & Giugliano, R. P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.017 · Cited by 182
Late Cardiac Effects of Cancer Treatment
Lenihan, D. J., & Cardinale, D. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2938 · Cited by 178
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms
Alexandre, J., Moslehi, J. J., Bersell, K. R., Funck‐Brentano, C., Roden, D. M., & Salem, J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.009 · Cited by 157
Self-citationNegishi, T., Thavendiranathan, P., Negishi, K., Marwick, T. H., Aakhus, S., Murbræch, K., Massey, R. J., Bansal, M., Fukuda, N., Hristová, K., et al. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.03.019 · Cited by 150
Puddu, P. E., Jouve, R., Mariotti, S., Giampaoli, S., Lanti, M., Reale, A., & Menotti, A. (1988) · Journal of Electrocardiology · doi:10.1016/0022-0736(88)90096-9 · Cited by 137
Bringhen, S., Milan, A., Ferri, C., Wäsch, R., Gay, F., Larocca, A., Salvini, M., Terpos, E., Goldschmidt, H., Cavo, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.191288 · Cited by 106
de Zwart, L., Snoeys, J., de Jong, J. D., Sukbuntherng, J., Mannaert, E., & Monshouwer, M. (2016) · Clinical pharmacology and therapy · doi:10.1002/cpt.419 · Cited by 103
Singh, A. P., Glennon, M. S., Umbarkar, P., Gupte, M., Galindo, C. L., Zhang, Q., Force, T. L., Becker, J. R., & Lal, H. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz006 · Cited by 96
Delluc, A., Wang, T., Yap, E. S., Ay, C., Schaefer, J. K., Carrier, M., & Noble, S. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14478 · Cited by 85
Alexandre, J., Salem, J., Moslehi, J. J., Sassier, M., Ropert, C., Cautela, J., Thuny, F., Éderhy, S., Cohen, A. A., Damaj, G. L., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa037 · Cited by 85
Self-citationGribben, J. G., Bosch, F., Cymbalista, F., Geisler, C. H., Ghia, P., Hillmen, P., Moreno, C., & Stilgenbauer, S. (2018) · British Journal of Haematology · doi:10.1111/bjh.15080 · Cited by 70
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors
Dobbin, S. J. H., Cameron, A. C., Petrie, M. C., Jones, R. J., Touyz, R. M., & Lang, N. N. (2018) · Heart · doi:10.1136/heartjnl-2018-313726 · Cited by 70
Bringhen, S., Milan, A., D’Agostino, M., Ferri, C., Wäsch, R., Gay, F., Larocca, A., Offidani, M., Zweegman, S., Terpos, E., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12882 · Cited by 65
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations
López‐Fernández, T., Martín‐Garcia, A., Rabadán, I. R., Mitroi, C. D., Mazón‐Ramos, P., Díez‐Villanueva, P., Escobar, C., Alonso‐Martín, C., Salinas, G. L. A., Arenas, M., et al. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.03.019 · Cited by 62
Monitoring Left Ventricular Function in Adults Receiving Anthracycline-Containing Chemotherapy
Belham, M., Kruger, A. R., Mepham, S., Faganello, G., & Pritchard, C. W. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.09.007 · Cited by 60
Cautela, J., Rouby, F., Salem, J., Alexandre, J., Scemama, U., Dolladille, C., Cohen, A. A., Paganelli, F. F., Éderhy, S., & Thuny, F. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.11.035 · Cited by 53
Self-citationÉderhy, S., Dolladille, C., Thuny, F., Alexandre, J., & Cohen, A. A. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1497 · Cited by 51
Self-citationCautela, J., Lalevée, N., Ammar, C., Éderhy, S., Peyrol, M., Debourdeau, P., Serin, D., Dolley, Y. L., Michel, N., Orabona, M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.046 · Cited by 41
Self-citation
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Shyam Sunder, S., Sharma, U. C., & Pokharel, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01469-6 · Cited by 508
Lustberg, M. B., Kuderer, N. M., Desai, A., Bergerot, C., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 306
Qi, X., Wang, S., Fang, C., Jia, J., Lin, L., & Yuan, T. (2025) · Redox Biology · doi:10.1016/j.redox.2024.103470 · Cited by 271
Metadata
- Authors
- Alexandre, J., Cautela, J., Ederhy, S., Damaj, G. L., Salem, J., Barlesi, F., Farnault, L., Charbonnier, A., Mirabel, M., Champiat, S., Cohen‐Solal, A., Cohen, A., Dolladille, C., & Thuny, F.
- Venue
- Journal of the American Heart Association
- Published
- 2020-09-15
- Volume
- 9
- Issue
- 18
- Pages
- e018403-e018403
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W3083694235
- Cited by
- 295
- References
- 71
- FWCI
- 22.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.